clinical trial · NCT07532902
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Diffuse Pleural MesotheliomaGastroesophageal CarcinomaUrothelial CarcinomaBMS-986504IpilimumabNivolumab5-FULeucovorinOxaliplatinGemcitabinePlatinum
brief summary
The researchers are doing this study to test the safety of BMS-986504 in combination with standard disease-specific anticancer medication in people with metastatic/advanced unresectable MTAP-deleted solid tumor cancer.
started
Apr 7, 2026
primary completion
Apr 1, 2029
completion
Apr 1, 2029
last updated
Apr 16, 2026
official title
A Phase 1a/1b Basket Trial of BMS-986504 With Standard-of-Care Therapy For Patients With Select Metastatic MTAP-deleted Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol